Tainted heart drug from second Chinese firm pulled off EU market
Heart drugs containing an active ingredient from a second Chinese company are being recalled from the European market after detection of a toxic impurity that may cause cancer.
from Reuters: Health News https://reut.rs/2vXMbZC
http://bit.ly/2zwRqiM
August 20, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on August 20, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.